← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications (1202)

• Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines. (2018/11/30) ♡
• Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients. (2018/11/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis. (2018/11/27) ♡
• Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis? (2018/11/26) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. (2018/11/15) ♡
• Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid. (2018/11/15) ♡
• In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [(18)F]DPA714 PET. (2018/11/13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study. (2018/11/12) ♡
• [B-cell Depletion Therapy in Multiple Sclerosis]. (2018/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive and translucent plaques on the soles. (2018/11/01) ♡
• Perspectives of Patients with Multiple Sclerosis on Drug Treatment: A Qualitative Study. (2018/11/01) ♡
• Expanding the Occupational Therapy Role to Support Transitions From Work to Retirement for People With Progressive Health Conditions. (2018/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients. (2018/10/31) ♡
• TLR3 agonism re-establishes CNS immune competence during α4-integrin deficiency. (2018/10/30) ♡
• What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT. (2018/10/18) ♡
• Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis. (2018/10/01) ♡
• Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease. (2018/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Rare Variant of Neuromyelitis Optica. (2018/10/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model. (2018/09/24) ♡
• Blood-brain barrier dysfunction in immuno-mediated neurological diseases. (2018/09/01) ♡
• Fair data for next-generation management of multiple sclerosis. (2018/08/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination. (2018/08/01) ♡
• Interactions between dietary inflammatory index, nutritional state and Multiple Sclerosis clinical condition. (2018/08/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. High intensity interval training for people with multiple sclerosis: A systematic review. (2018/08/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gender-Specific Association of Leptin and Adiponectin Genes With Multiple Sclerosis. (2018/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Special Considerations and Assessment in Patients with Multiple Sclerosis. (2018/08/01) ♡
• Monthly Pulse Methylprednisolone Therapy is Effective in Preventing Permanent Disease Progression in Secondary Progressive Multiple Sclerosis. (2018/07/06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects. (2018/07/01) ♡
• How patients with multiple sclerosis weigh treatment risks and benefits. (2018/07/01) ♡
• The effect of evening primrose oil on fatigue and quality of life in patients with multiple sclerosis. (2018/06/12) ♡
• A hybrid approach based on logistic classification and iterative contrast enhancement algorithm for hyperintense multiple sclerosis lesion segmentation. (2018/06/01) ♡
• Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. (2018/05/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effects of Classic Progressive Resistance Training Versus Eccentric-Enhanced Resistance Training in People With Multiple Sclerosis. (2018/05/01) ♡
• Evaluating the Association between Enlarged Perivascular Spaces and Disease Worsening in Multiple Sclerosis. (2018/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ocrelizumab: A New B-cell Therapy for Relapsing Remitting and Primary Progressive Multiple Sclerosis. (2018/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts. (2018/05/01) ♡
• A survey of dietary characteristics in a large population of people with multiple sclerosis. (2018/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple sclerosis. (2018/04/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring Wellness Interventions in Progressive Multiple Sclerosis: an Evidence-Based Review. (2018/04/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extracellular vesicles in neurodegenerative diseases. (2018/04/01) ♡
• The use of satellite data to measure ultraviolet-B penetrance and its potential association with age of multiple sclerosis onset. (2018/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review. (2018/03/17) ♡
• The era of GWAS is over - No. (2018/03/01) ♡
• Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optical coherence tomography in diagnosis and monitoring multiple sclerosis. (2018/03/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function. (2018/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Surgical Management of Encapsulating Peritoneal Sclerosis: A Case Report in Kidney Transplant Patient. (2018/02/21) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD). (2018/02/01) ♡
• Erratum. (2018/02/01) ♡
• Multiple Sclerosis with Onset Younger Than 10 Years in Turkey. (2018/02/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.